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Background: Pain being one of the many symptoms experienced in the course of an infection, this study was designed 
to investigate antinociceptive activity of two medicinal plants used to treat malaria traditionally. In traditional health 
practice there is usually a misunderstanding on whether the plants clear the disease causing organism or they cure 
the pain as one of the most common symptoms. The plants were selected based on their ethnomedical literature as a 
means of establishing a distinction between their antinociceptive and bio-activities. 
Objective: To determine antinociceptive effect of Pentas lanceolata and Ximenia americana.  
Materials and Methods: The aerial parts of P. lanceolata and the stem bark of X. americana were collected from 
Kiangombe forest and Kerio Valley in Embu and Elgeyo Marakwet Counties respectively. The collection was done with 
the help of an experienced taxonomist. The plant parts were dried, and extracted with methanol and aqueous 
solvents. Analgesic activity was determined by the tailflick and formalin test techniques in male albino mice. The 
positive control used in the experiment was acetylsalicylic acid (ASA) at 100 mg/kg.  
Results: Antinociceptive activity of the plant extracts in the tail flick assay was time and dose dependent, except in the 
case of P. lanceolata methanol extract. In the formalin test, the extracts significantly (p<0.05) reduced the time spent 
in pain behavior in both the early and late phases  
Conclusion: The results of this study support the use of these plants to manage pain and imply other pharmacological 
benefits to the host other than parasiticidal effect in malaria treatment.  
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1. Introduction 
Pain is a vital function of the nervous system in 
providing the body with a warning of potential or actual 
injury. The nervous system detects and interprets a 
wide range of thermal and mechanical stimuli, as well as 
environmental and endogenous chemical irritants. 
When intense, these stimuli generate acute pain, and in 
the setting of persistent injury, both peripheral and 
central nervous system components of the pain 
transmission pathway exhibit tremendous plasticity, 
enhancing pain signals and producing hypersensitivity. 
Nociceptors are the specialised sensory receptors 
responsible for the detection of noxious (unpleasant) 
stimuli, transforming the stimuli into electrical signals, 
which are then conducted to the central nervous 
system. Pain experienced due to infections is known as 
neuropathic pain which is caused by damage to nerves 
in the central or peripheral nervous system (Basbaum 
and Jessell, 2000; Basbaum et al, 2009). Pain being one 
of the many symptoms experienced in the course of an 
infection, this study was designed to investigate 
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antinociceptive activity of some selected medicinal 
plants with the aim of trying to demystify the ability of 
the plants, to cure the pain as one of the most common 
symptoms of many infections, rather than their ability 
to clear the disease causing organism; a 
misunderstanding that occurs in traditional health 
practice. The plants were selected based on their 
ethnomedical literature described below, as a means of 
establishing a distinction between their antinociceptive 
and bio-activities. 
Pentas lanceolata is an upright tropical evergreen 
shrub, 3 - 4 feet tall. The juice from the roots of P. 
lanceolata locally known as Olkilaki-olkerr (Maasai) is 
drunk for malaria and depression (Kokwaro, 1993). The 
plant has been shown to exhibit antimalarial activity 
(Koch et al, 2005; Rotich et al, 2015). It also has 
antibacterial activity (Matu et al, 2012). 
Ximeina americana L. is a small tree up to 8 m high. It 
belongs to the family olacaceae and is widely used to 
treat various ailments like malaria in Nigeria (Ogunleye 
and Ibitoye, 2003), skin infections, leprosy and 
Trypanosoma Congolese infection (Adieza and Minda, 
2011). In Sudan, the leaves and twigs are traditionally 
used to treat colds, fevers, headaches, sleeping sickness, 
oedema, used as laxatives, and as a poison antidote. The 
bark is used for kidney and heart complaints as well as 
headaches and skin ulcers (Abdalla et al, 2013) In 
Kenya its locally known as Ol-amai (Maasai). The seed 
oil is used to treat cracking feet. The root decoction 
syphilis, diarrhea and hookworm. The leaf measles and 
stomachache and the fruit for tonsillitis and mouthsores 
(Dharani 2011; Kokwaro, 2009). 
The use of X. americana in traditional medicine has been 
verified for certain disorders, anticancer (Voss et al, 
2006b), antitrypanosomal (Maikai et al, 2008), 
antimicrobial (Maikai et al, 2009), anti-inflammatory 
(Soro et al, 2009a), antimalarial Rotich et al, 2015). 
Analgesic activity of extracts of X. americana leaves has 
also been elucidated (Siddaiah et al, 2009).  
In 2013, the World Health Organization (WHO) 
recommended the integration of traditional medicines 
proved to be useful into national health care 
programmes (WHO Traditional Medicine Strategy 
2014–2023). Plant-derived natural products are rich 
resources in drug development, considering, 68% of all 
pharmaceuticals are from plants or are plant inspired 
(Zhu et al, 2012). Taking this into account, this study 
sought to investigate the analgesic properties of P. 
lanceolata and X. americana. 
2. Materials and Methods 
2.1 Collection of plant material 
Plants specimen were collected with the help of an 
experienced taxonomist, authenticated and voucher 
specimens deposited at the East African Herbarium 
National Museums, of Kenya.  
Aerial parts of Pentas lanceolata were collected from 
Kiangombe forest, Siakago, Embu County while Ximenia 
americana stem bark was collected from Kerio Valley, 
Elgeyo Marakwet County in Kenya (Table 1).  
Table 1: Plants parts collected, location and voucher 
numbers 






















2.2 Extraction of plant material 
The plant parts were air dried at room temperature 
under shade and pulverized using a laboratory mill. The 
resulting powders were packed in air tight polythene 
bags, labeled and stored in the dark until used.  
Each plant sample was extracted with water and 
methanol. For the methanol extracts 50 g of the 
powdered plant material was macerated with 500 ml of 
methanol at room temperature for 24 h and filtered 
through Whatman filter paper No. 1. The plant material 
was re-extracted with 300 ml methanol for the same 
period and the filtrates pooled and concentrated under 
vacuum at 40 °C until dry. The concentrate was weighed 
and transferred to an air tight sample bottle and stored 
at 4 °C until used. Another 50 g of the same sample was 
extracted once with 500 ml of distilled water in a water 
bath at 60 °C for 1 h, filtered and lyophilized in a freeze 
dryer. The dry extracts for all the samples similarly 
treated were weighed into airtight containers and 
stored at 4 °C until used. 
2.3 Drugs and test agents 
Acetylsalicylic acid (ASA) (CSPC OUYI Pharmaceutical 
Co. Ltd, China, Batch No. 130339) was used as a 
reference drug. Formalin used was of analytical grade. 
Sterile normal saline was used as a negative control 
(0.2ml per animal). ASA (100mg/kg) and extracts 
(100mg/kg, 200mg/kg) were dissolved in normal saline 
on the day of the experiment prior to use. 
2.4 Experimental Animals  
Male Swiss albino mice weighing 25-30 grams were 
used for both the tail flick and formalin test. Food and 
water were given ad libitum. Animals were allowed 7 
days for acclimatization. They were kept at temperature 
of 22º C to 25º C and relative humidity of 50%. The 
experiments were conducted as per the guidelines 
issued by the International Association for the Study of 
Pain in experimental animals (Zimmermann, 1983). 
2.4 Tail –Flick test 
The tail flick test measures the response threshold of 
high intensity heat stimuli when applied to the animal’s 
tail. The latency between onset of the stimulus and a 
rapid withdrawal of the tail is noted and recorded in 
seconds. The mice were brought to the test room, their 
weight recorded and then they were allowed to 
acclimatize to the test environment. Baseline latencies 
of the animals were recorded and the intensity of the 
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heat adjusted to produce latencies of 3 to 4 seconds. The 
light beam was focused approximately 15mm from the 
tip. The stimulus cutoff was set at 10 seconds to avoid 
tissue damage in the absence of a withdrawal reflex. 
The mice were treated with the plant extracts (100 and 
200 mg/kg, i.p.) or acetylsalicylic acid (ASA) 100mg/kg, 
i.p. as a reference drug 30 min before the experiment 
and observed after 30 min and 1 hr. The time from 
onset of stimulation to a rapid flick of the tail from the 
light beam was recorded. 
2.5 Formalin test 
The method used, was similar to that described 
previously (Hunskaar and Hole, 1987) with slight 
modifications. Mice were removed from their initial 
cages, weight taken and then allowed to acclimate for 
30 min in the test environment. They were then 
randomly grouped into groups of six and pretreated 30 
min prior to the formalin injection with either the plant 
extracts (200 mg/kg, i.p), normal saline or ASA (100 
mg/kg, i.p). The normal saline and ASA served as the 
negative and positive controls respectively. The mice 
were then injected with 20µl of 5% formalin on the 
dorsal surface of the right hind paw and immediately 
returned to the observation chamber. The time (in 
seconds) spent in licking and biting of the injected paw 
by the animals, was taken as an indicator of nociception 
response. This was measured for 0-10 min (first phase) 
and 15-30min second phase after formalin injection. 
The data was presented as mean ± s.e.m of time(s) 
spent in pain behavior. The mean of time (s) spent in 
pain behavior for the extract was compared with that of 
the control. The formalin test model is biphasic, it 
measures both neurogenic pain (first phase) and 
inflammatory pain (second phase) (Adzu et al, 2014). 
2.6 Data analysis 
Results were expressed as Mean±SEM. The data was 
analyzed using one-way analysis of Variance (ANOVA) 
test and subsequently subjected to turkey post hoc test 
for multiple comparisons p<0.05 were considered 
statistically significant. 
3.  Results  
3.1 Evaluation of pain in the tail flick assay 
The results of the tail flick test revealed significant 
(p<0.05) antinociceptive activity of the plant extracts 
when compared to the control. However the group 
given X. americana extracts at a dose of 100 mg/kg i.p 
had insignificant reaction time at 30 min of the 
observation period. The reaction time for the mice given 
the plant extracts increased at one hour of the 
observation period, with the exception of P. lanceolata 
methanol extract. This was also true for the dosage 
whereby the reaction time increased with increase in 
dosage except for P. lanceolata water extract.  The 
standard drug acetylsalicylic acid (aspirin) at a dose of 
100 mg/kg had little analgesic activity (Table 2). Three 
out of the six mice, given X. americana extracts at a dose 
of 200 mg/kg i.p. died within 24 hours. 
3.2 Evaluation of the formalin induced pain 
In general, the plant extracts significantly (p<0.05)  
reduced the time spent in pain behavior in both the 
early(0-10 min) and late (15-40 min) phases compared 
to normal saline which acted as the negative control 
(Figure 1). The antinociceptive effect of the water and 
methanol extract of P. lanceolata was not significantly 
different (p=0.367) from that of acetyl salicylic acid in 
the first phase. The same pattern was witnessed again 
in the second phase with the exception of P. lanceolata 
water extract. The water and methanol extracts of X. 
americana had better activity than acetyl salicylic acid 
which was the reference drug in the two phases. The 
activity of X. americana methanol extract was superior 
to ASA and all the other plant extracts (Table 3). 
 
   Table 2 Antinociceptive activity of P. lanceolata and X. americana in the tail flick assay 
 Extracts Plant parts 
Dose  
(mg/kg, i.p) 
Response time (in seconds) 
After 30 min After 1 hour 
Water extracts 
P. lanceolata Aerial parts 100 7.27±1.10 7.77±1.09 
P. lanceolata Aerial parts 200 4.95±0.83 6.27±1.07 
X. americana Stem bark 100 3.52±0.36 5.72±1.06 
X. americana Stem bark 200 6.83±1.11 7.47±0.88 
Methanol extracts 
P. lanceolata  Aerial parts 100 5.65±0.99 4.21±0.39 
P. lanceolata Aerial parts 200 6.86±1.22 4.37±0.82 
X. americana Stem bark 100 3.92±0.51 5.37±0.95 
X. americana Stem bark 200 4.42±0.55 7.80±1.15 
Control   3.63±0.43 3.2±0.47 
ASA  100 4.76±1.04 4.67±0.86 
   Values expressed as mean± S.E.M of 6 animals.  
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   Table 3: Effect of X. americana and P. lanceolata on the formalin test 
Treatment  Dose (mg/kg i.p) 
Phase one 
Time spent in pain 
behavior. (Sec.) 
Phase two 
Time spent in pain 
behavior. (Sec.) 
X. americana methanol extract 200 10.83±1.14 14.00±1.92 
X. americana water extract 200 15.17±1.49 29.33±6.01 
P. lanceolata methanol extract 200 25.67±1.65 51.33±8.39 
P. lanceolata water extract 200 29.00±3.30 31.00±3.80 
Normal Saline - 45.67±2.91 85.50±1.88 
ASA 100 31.67±1.23 53.33±2.03 
   Values are mean± SE of 6 animals.  
 
  
Figure 1: Effects of methanol extract of X. americana (METXEM), water extract of X. americana (WATXEM), methanol 
extract of P. lanceolata (METPEM) and water extract of P. lanceolata (WATPEM)on the formalin test 
 
3.2 Evaluation of the formalin induced pain 
In general, the plant extracts significantly (p<0.05)  
reduced the time spent in pain behavior in both the 
early(0-10 min) and late (15-40 min) phases compared 
to normal saline which acted as the negative control 
(Figure 1). The antinociceptive effect of the water and 
methanol extract of P. lanceolata was not significantly 
different (p=0.367) from that of acetyl salicylic acid in 
the first phase.  
The same pattern was witnessed again in the second 
phase with the exception of P. lanceolata water extract. 
The water and methanol extracts of X. americana had 
better activity than acetyl salicylic acid which was the 
reference drug in the two phases. The activity of X. 
americana methanol extract was superior to ASA and all 
the other plant extracts (Table 3). 
4. Discussion 
In this study, the two plants P. lanceolata and X. 
ameriacana exhibited potent analgesic activity in both 
phases of the formalin test, with methanol extract of X. 
americana showing superior antinociceptive activity. 
The formalin test model is biphasic, and measures both 
neurogenic pain (first phase), and inflammatory pain 
(second phase) (Adzu et al, 2014).  
The first phase is a short response which is deemed to 
reflect the activity of C-fiber afferent nociceptors. The 
second phase follows a short inactive period. It is 
continous and prolonged and is thought to be due to 
central sensitization of the spinal dorsal horn neurons 
as a result of the initial onslaught from C-fiber 
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The results for this study justify the use of the two 
plants to manage pain by herbalists. The results also 
indicate that other than the direct parasiticidal effect 
supported by various papers (Koch at el., 2005; Rotich 
et al, 2015) in the treatment of malaria, the two plants 
also posses other pharmacological benefits to the host 
for instance acting as analgesics. In Kenya the two 
plants are used to treat malaria locally. Malaria presents 
with fever, headache, muscle pains chills, vomiting and 
general malaise (CDC, 2014).  
Water and methanol extracts of the aerial parts of P. 
lanceolata at a dose of 200mg/kg i.p. significantly 
(p<0.05) reduced pain in the formalin test and was 
comparable to ASA the reference drug. Other parts of 
the two plants have been shown to have antinociceptive 
activity in other studies too. Ethanol and ethyl acetate of 
the leaf extracts of P. lanceolata was shown to have 
analgesic activity in the acetic acid induced writhing 
method (Suman et al, 2014). Hemamalini et al, 2011 
reported analgesic potential of the methanol extract of 
X. americana leaf in the tail flick and hot plate tests as 
well. 
Even though methanol extract of X. americana stem 
bark, was seen to have better activity, at 200mg/kg i.p. 
In the tail flick assay, 3 out of 6 mice, died within 24 
hours indicating that this extract was toxic at that dose. 
This implies that care should be taken in the 
administration of the stem bark extracts of X. 
americana. Rotich et al (2015) reported toxicity of the 
stem bark extracts of X. americana in the acute toxicity 
assay too. Toxicity of other parts of this plant has been 
reported as well in other studies, for instance, toxicity of 
the roots (Voss et al, 2006a; Soro et al, 2009b; Olabissi 
et al, 2011) and leaves by (Kamita et al, 2014) has been 
reported. 
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